Human DDIT4 (REDD-1) knockout HeLa cell lysate (ab257409)
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 1 kit ab260224 - Human DDIT4 knockout HeLa cell lysate 1 x 100µg ab255552 - Human wild-type HeLa cell lysate 1 x 100µg -
Research areas
-
Cell type
epithelial -
Disease
Adenocarcinoma -
Gender
Female -
STR Analysis
Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8, 12 CSF1PO: 9, 10
Images
-
Western blot - Human DDIT4 knockout HeLa cell lysate (ab257409)
Lane 1:Wild-type HeLa cell lysate (20 ug)
Lane 2:DDIT4 knockout HeLa cell lysate (20 ug)
Lane 3:HeLa treated with 0.5mM CoCL2 for 6 hours cell lysate (20 ug)
Lane 4:Untreated HeLa cell lysate (20 ug)ab191871 Anti-REDD-1/DDIT4 antibody [EPR18716] was shown to specifically react with REDD-1/DDIT4 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264834 (knockout cell lysate ab257409) was used. Wild-type and REDD-1/DDIT4 knockout samples were subjected to SDS-PAGE. ab191871 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
-
Sanger Sequencing - Human DDIT4 knockout HeLa cell lysate (ab257409)Homozygous: 1 bp insertion in exon 2
